Peter Kojo Quashie profile image

Peter Kojo Quashie

ASSOCIATE PROFESSOR

Google Scholar
Verified email at ug.edu.gh University of Ghana Google Scholar

CollegeCOLLEGE OF BASIC & APPLIED SC.
School / InstituteCOLLEGE OF BASIC & APPLIED SC.
DepartmentWEST AFRICAN CENTRE FOR CELL BIOLOGY OF INFECTIOUS PATHOGENS
Virology
Publications

114

Citations

3,152

H-index

29

i10-index

51

Publication activity
Publication statistics
Average citations
27.6
Most cited paper
289
First publication year
1900
Latest publication year
2026
Last updated
13 Sep 2026, 23:48
Publications

114 matching publications

PublicationYearJournalThematic areaCitations
Dolutegravir HIV integrase inhibitor treatment of HIV infection
MA Wainberg, PK Quashie, T Mesplede
2012 Drugs of the Future 37 (10), 697-707, 2012 Health Sciences 10
In vitro analysis suggests that SARS-CoV-2 infection differentially modulates cancer-like phenotypes and cytokine expression in colorectal and prostate cancer cells
A Serwaa, F Oyawoye, IA Owusu, D Dosoo, AA Manu, AK Sobo, K Fosu, ...
2024 Scientific Reports 14 (1), 24625, 2024 Health Sciences 9
Development of an Affordable ELISA Targeting the SARS-CoV-2 Nucleocapsid and Its Application to Samples from the Ongoing COVID-19 Epidemic in Ghana: K. Tapela et al.
K Tapela, PC Opurum, FY Nuokpem, B Tetteh, GK Siaw, MV Humbert, ...
2023 Molecular Diagnosis & Therapy 27 (5), 583-592, 2023 Natural Sciences 9
Explaining the unexpected COVID-19 trends and potential impact across Africa
D Oduro-Mensah, E Oduro-Mensah, P Quashie, G Awandare, L Okine
2022 F1000Research 10, 1177, 2022 Natural Sciences 9
Subtype-specific analysis of the K65R substitution in HIV-1 that confers hypersusceptibility to a novel nucleotide-competing reverse transcriptase inhibitor
HT Xu, SP Colby-Germinario, PK Quashie, R Bethell, MA Wainberg
2015 Antimicrobial Agents and Chemotherapy 59 (6), 3189-3196, 2015 Health Sciences 9
Cuba’s COVID-19 Vaccine Enterprise: Report from a High-Level Fact-Finding Delegation to Cuba
MT Osterholm, C Rabadán-Diehl, J Anzinger, ME Bottazzi, ...
2022 Medicc Review 24 (3-4), 2022 Natural Sciences 8
Biochemical analysis of the role of G118R-linked dolutegravir drug resistance substitutions in HIV-1 integrase
PK Quashie, T Mesplède, YS Han, T Veres, N Osman, S Hassounah, ...
2014 Antimicrobial agents and chemotherapy 58 (1), 633-633, 2014 Health Sciences 8
HIV-1 group O integrase displays lower enzymatic efficiency and higher susceptibility to raltegravir than HIV-1 group M subtype B integrase
A Depatureaux, PK Quashie, T Mesplède, Y Han, H Koubi, JC Plantier, ...
2014 Antimicrobial Agents and Chemotherapy 58 (12), 7141-7150, 2014 Health Sciences 8
The Confluence of HIV‐1 and HIV‐2: Implications for Disease Progression and Insights for Therapy
E Magomere, CO Olwal, BE Tetteh, M Appeaning, T Ndung’u, GB Kyei, ...
2025 International Journal of Microbiology 2025 (1), 3145677, 2025 Health Sciences 7
The urgent need for newer drugs in routine HIV treatment in Africa: the case of Ghana
SNA Appiedu-Addo, M Appeaning, E Magomere, GA Ansa, EY Bonney, ...
2025 Frontiers in Epidemiology 5, 1523109, 2025 Health Sciences 7
Upper Airway Epithelial Tissue Transcriptome Analysis Reveals Immune Signatures Associated with COVID‐19 Severity in Ghanaians
JD Sandi, JI Levy, K Tapela, M Zeller, JA Yeboah, DF Saka, DS Grant, ...
2024 Journal of Immunology Research 2024 (1), 6668017, 2024 Natural Sciences 6
Selection in culture of HIV resistance to dolutegravir by mutations at integrase positions R263K and H51Y that diminish viral replication fitness
T Mesplede, P Quashie, M Oliveira, M Underwood, R Wang, T Fujiwara, ...
2012 Journal of the International AIDS Society 15, 1-1, 2012 Health Sciences 6
Adults in Ghana generate higher and more durable neutralising antibody titres following primary course COVID-19 vaccination than matched UK adults: The HERITAGE Study
EM Kwesi-Maliepaard, Y Alhassan, EK Quaye, VM Kotey, AM Mohammed, ...
2025 BMC medicine 23 (1), 312, 2025 Humanities 5
Moremi bio agent: Application of a foundation model and end-to-end automation in the design and validation of monoclonal antibodies targeting plasmodium falciparum invasion complex
D Akogo, J Ayensu, N Sam, G Hattoh, P Nyarko, S Eshun, M Alhasan, ...
2025 bioRxiv, 2025.02. 12.637967, 2025 Natural Sciences 4
Knowledge, attitude and perception towards COVID-19 among representative educated sub-Saharan Africans: A cross-sectional study during the exponential phase of the pandemic
AJ Udoakang, NN Nganyewo, AL Djomkam Zune, CO Olwal, NAA Etim, ...
2024 Plos one 19 (2), e0281342, 2024 Natural Sciences 4
HIV-1 group O integrase displays lower susceptibility to raltegravir and has a different mutational pathway for resistance than HIV-1 group M
A Depatureaux, T Mesplede, P Quashie, M Oliveira, D Moisi, B Brenner, ...
2014 Journal of the International AIDS Society 17, 2014 Health Sciences 4
Biochemical characterization of TyrA enzymes from Ignicoccus hospitalis and Haemophilus influenzae: a comparative study of the bifunctional and monofunctional dehydrogenase forms
I Shlaifer, PK Quashie, HY Kim, JL Turnbull
2017 Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1865 (3), 312-320, 2017 Natural Sciences 3
In vitro and structural evaluation of PL-100 as a potential second-generation HIV-1 protease inhibitor
EL Asahchop, M Oliveira, PK Quashie, D Moisi, JL Martinez-Cajas, ...
2013 Journal of Antimicrobial Chemotherapy 68 (1), 105-112, 2013 Health Sciences 3
610 Wainberg MA. 2011. Compensation by the E138K mutation in HIV-1 reverse 611 transcriptase for deficits in viral replication capacity and enzyme processivity 612 associated …
HT Xu, EL Asahchop, M Oliveira, PK Quashie, Y Quan, BG Brenner
1900 J Virol 85, 11300-11308, 0 Health Sciences 3
Functional antibody responses to SARS-CoV-2 variants before and after booster vaccination among adults in Ghana
FD Partey, ANA Pobee, IK Damptey, F Osei, M Owusu-Amponsah, ...
2025 Experimental Biology and Medicine 250, 10440, 2025 Natural Sciences 2
Slow virologic control but strong immune and metabolic recovery with dolutegravir-anchored therapy in an HIV cohort in Ghana
M Appeaning, E Magomere, AM Abotsi, NAY Amoako, KE Kouffie, ...
2025 Virology Journal 22 (1), 247, 2025 Health Sciences 2
Understanding the role of oral and vaginal microbiomes in HPV-related cervical, head, and neck cancers: knowledge gaps and feasibility in Sub-Saharan Africa
HE Kamassa, G Katawa, A Isawumi, C Olwal, WS Gbewonyo, PK Quashie, ...
2025 Frontiers in Microbiomes 4, 1576394, 2025 Natural Sciences 2
Molecular epidemiology of Infectious Spleen and Kidney Necrosis Virus (ISKNV) in Ghanaian cultured tilapia
ANA Ayiku, AA Adelani, P Appenteng, M Nkansah, JM Ngoi, ...
2022 BioRxiv, 2022.11. 15.516701, 2022 Health Sciences 2
HIV resistance to dolutegravir (DTG) simultaneously diminishes viral DNA integration into host cells and viral replication fitness: implications for HIV reservoirs
T Mesplede, P Quashie, M Oliveira, M Wainberg
2013 7th IAS Conference on HIV pathogenesis treatment and prevention. Kuala …, 2013 Health Sciences 2
JAK-STAT and IL-17 pathway dysregulation underlies persistent immune dysfunction in ART-experienced people living with HIV in Ghana
M Appeaning, E Magomere, NAY Amoako, KE Kouffie, K Tapela, ...
2026 Frontiers in Immunology 17, 1753475, 2026 Health Sciences 1